MiNK Therapeutics, Inc. (INKT) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $13.36M | +191.9% |
| 2024 | $4.58M | +35.9% |
| 2023 | $3.37M | -82.9% |
| 2022 | $19.64M | -49.5% |
| 2021 | $38.89M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $13.36M | +191.9% |
| 2024 | $4.58M | +35.9% |
| 2023 | $3.37M | -82.9% |
| 2022 | $19.64M | -49.5% |
| 2021 | $38.89M | — |